Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 504

1.

Exploring Integrative Analysis Using the BioMedical Evidence Graph.

Struck A, Walsh B, Buchanan A, Lee JA, Spangler R, Stuart JM, Ellrott K.

JCO Clin Cancer Inform. 2020 Feb;4:147-159. doi: 10.1200/CCI.19.00110.

2.

Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study.

Lipton RB, Lombard L, Ruff DD, Krege JH, Loo LS, Buchanan A, Melby TE, Buse DC.

J Headache Pain. 2020 Feb 24;21(1):20. doi: 10.1186/s10194-020-01088-4.

3.

Design and Reporting Considerations for Genetic Screening Tests.

Hagenkord J, Funke B, Qian E, Hegde M, Jacobs KB, Ferber M, Lebo M, Buchanan A, Bick D.

J Mol Diagn. 2020 Feb 22. pii: S1525-1578(20)30038-6. doi: 10.1016/j.jmoldx.2020.01.014. [Epub ahead of print] Review.

PMID:
32092541
4.

Evaluating the effect of individually-targeted food incentives on grocery purchases: The smart cart study protocol for a randomized controlled cross-over trial.

Vadiveloo MK, Guan X, Parker HW, Perraud E, Buchanan A, Atlas S, Thorndike AN.

Contemp Clin Trials. 2020 Feb 21;91:105966. doi: 10.1016/j.cct.2020.105966. [Epub ahead of print]

PMID:
32092439
5.

The ABCs of Ocular Trauma: Adapting a Familiar Mnemonic for Rapid Eye Exam in the Pre-Ophthalmic Zone of Care.

Kroesen CF, Snider M, Bailey J, Buchanan A, Karesh JW, La Piana F, Seefeldt E, Egan JA, Mazzoli RA.

Mil Med. 2020 Jan 7;185(Suppl 1):448-453. doi: 10.1093/milmed/usz262.

PMID:
32074325
6.

Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program.

Hao J, Hassen D, Manickam K, Murray MF, Hartzel DN, Hu Y, Liu K, Rahm AK, Williams MS, Lazzeri A, Buchanan A, Sturm A, Snyder SR.

J Pers Med. 2020 Feb 3;10(1). pii: E7. doi: 10.3390/jpm10010007.

7.

Logic Model of the Department of Veterans Affairs' Role in Veterans Treatment Courts.

Finlay AK, Clark S, Blue-Howells J, Claudio S, Stimmel M, Tsai J, Buchanan A, Rosenthal J, Harris AHS, Frayne S.

Drug Court Rev. 2019 Summer;2:45-62.

PMID:
32016172
8.

A community effort to create standards for evaluating tumor subclonal reconstruction.

Salcedo A, Tarabichi M, Espiritu SMG, Deshwar AG, David M, Wilson NM, Dentro S, Wintersinger JA, Liu LY, Ko M, Sivanandan S, Zhang H, Zhu K, Ou Yang TH, Chilton JM, Buchanan A, Lalansingh CM, P'ng C, Anghel CV, Umar I, Lo B, Zou W; DREAM SMC-Het Participants, Simpson JT, Stuart JM, Anastassiou D, Guan Y, Ewing AD, Ellrott K, Wedge DC, Morris Q, Van Loo P, Boutros PC.

Nat Biotechnol. 2020 Jan;38(1):97-107. doi: 10.1038/s41587-019-0364-z. Epub 2020 Jan 9.

PMID:
31919445
9.

Developing an effective inpatient learning climate.

Harper BD, Buchanan AO, Cramton RE, Gourishankar A, King M, Molas-Torreblanca K, Patra KP, Pomeroy B, Potisek NM, Seelbach E, Tomaszewski JL, Fromme HB.

Clin Teach. 2019 Dec 11. doi: 10.1111/tct.13121. [Epub ahead of print] No abstract available.

PMID:
31828976
10.

"Just one of the guys" An application of the Occupational Wellbeing framework to graduates of a Men's Shed Program for young unemployed adult males with intellectual disability.

Milbourn B, Mahoney N, Trimboli C, Hoey C, Cordier R, Buchanan A, Wilson NJ.

Aust Occup Ther J. 2019 Nov 26. doi: 10.1111/1440-1630.12630. [Epub ahead of print]

PMID:
31769055
11.

Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.

Liu G, Byrd A, Warner AN, Pei F, Basha E, Buchanan A, Buchan JR.

Mol Cell Biol. 2020 Jan 30;40(4). pii: e00256-19. doi: 10.1128/MCB.00256-19. Print 2020 Jan 30.

PMID:
31767634
12.

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans.

Knievel K, Buchanan AS, Lombard L, Baygani S, Raskin J, Krege JH, Loo LS, Komori M, Tobin J.

Cephalalgia. 2020 Jan;40(1):19-27. doi: 10.1177/0333102419889350. Epub 2019 Nov 19.

13.

Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.

Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, Buchanan AL, Coderre T, Boss R, Rich JD, Marshall BDL.

PLoS Med. 2019 Nov 19;16(11):e1002963. doi: 10.1371/journal.pmed.1002963. eCollection 2019 Nov.

14.

Design and Implementation of a Lifestyle Medicine Curriculum in Undergraduate Medical Education.

Trilk JL, Elkhider IA, Asif I, Buchanan A, Emerson J, Kennedy AB, Masocol R, Motley E, Tucker M.

Am J Lifestyle Med. 2019 Apr 3;13(6):574-585. doi: 10.1177/1559827619836676. eCollection 2019 Nov-Dec.

PMID:
31662724
15.

Reproducible biomedical benchmarking in the cloud: lessons from crowd-sourced data challenges.

Ellrott K, Buchanan A, Creason A, Mason M, Schaffter T, Hoff B, Eddy J, Chilton JM, Yu T, Stuart JM, Saez-Rodriguez J, Stolovitzky G, Boutros PC, Guinney J.

Genome Biol. 2019 Sep 10;20(1):195. doi: 10.1186/s13059-019-1794-0.

16.

Corrigendum: In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry.

Saylor RA, Hersey M, West A, Buchanan AM, Berger SN, Nijhout HF, Reed MC, Best J, Hashemi P.

Front Neurosci. 2019 Jul 9;13:726. doi: 10.3389/fnins.2019.00726. eCollection 2019.

17.

Impact of a Yoga and Meditation Intervention on Students' Stress and Anxiety Levels.

Lemay V, Hoolahan J, Buchanan A.

Am J Pharm Educ. 2019 Jun;83(5):7001. doi: 10.5688/ajpe7001.

18.

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.

Krege JH, Rizzoli PB, Liffick E, Doty EG, Dowsett SA, Wang J, Buchanan AS.

Cephalalgia. 2019 Jul;39(8):957-966. doi: 10.1177/0333102419855080. Epub 2019 Jun 5.

19.

Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.

Tepper SJ, Krege JH, Lombard L, Asafu-Adjei JK, Dowsett SA, Raskin J, Buchanan AS, Friedman DI.

Headache. 2019 Jul;59(7):1052-1062. doi: 10.1111/head.13544. Epub 2019 Jun 1. Erratum in: Headache. 2019 Nov;59(10):1875.

PMID:
31152441
20.

In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry.

Saylor RA, Hersey M, West A, Buchanan AM, Berger SN, Nijhout HF, Reed MC, Best J, Hashemi P.

Front Neurosci. 2019 Apr 23;13:362. doi: 10.3389/fnins.2019.00362. eCollection 2019. Erratum in: Front Neurosci. 2019 Jul 09;13:726.

21.

Interpretation of the Individual Effect Under Treatment Spillover.

Crawford FW, Morozova O, Buchanan AL, Spiegelman D.

Am J Epidemiol. 2019 Aug 1;188(8):1407-1409. doi: 10.1093/aje/kwz108.

PMID:
31094425
22.

Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design.

Cannon DA, Shan L, Du Q, Shirinian L, Rickert KW, Rosenthal KL, Korade M 3rd, van Vlerken-Ysla LE, Buchanan A, Vaughan TJ, Damschroder MM, Popovic B.

PLoS Comput Biol. 2019 May 1;15(5):e1006980. doi: 10.1371/journal.pcbi.1006980. eCollection 2019 May.

23.

Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA.

Aroke HA, Vyas AM, Buchanan AL, Kogut SJ.

Drugs Real World Outcomes. 2019 Jun;6(2):73-82. doi: 10.1007/s40801-019-0153-5.

24.

Correlates of Future Violence in People Being Treated for Schizophrenia.

Buchanan A, Sint K, Swanson J, Rosenheck R.

Am J Psychiatry. 2019 Sep 1;176(9):694-701. doi: 10.1176/appi.ajp.2019.18080909. Epub 2019 Apr 24.

PMID:
31014102
25.

Older male mentors: Outcomes and perspectives of an intergenerational mentoring program for young adult males with intellectual disability.

Mahoney N, Wilson NJ, Buchanan A, Milbourn B, Hoey C, Cordier R.

Health Promot J Austr. 2020 Jan;31(1):16-25. doi: 10.1002/hpja.250. Epub 2019 May 1.

PMID:
30959560
26.

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

Viani RM, Ruel T, Alvero C, Fenton T, Acosta EP, Hazra R, Townley E, Palumbo P, Buchanan AM, Vavro C, Singh R, Graham B, Anthony P, George K, Wiznia A; P1093 Study Team .

J Pediatric Infect Dis Soc. 2019 Apr 5. pii: piy139. doi: 10.1093/jpids/piy139. [Epub ahead of print]

PMID:
30951600
27.

Interactions Between the Gravitostat and the Fibroblast Growth Factor System for the Regulation of Body Weight.

Palsdottir V, Windahl SH, Hägg DA, Keantar H, Bellman J, Buchanan A, Vaughan TJ, Lindén D, Jansson JO, Ohlsson C.

Endocrinology. 2019 May 1;160(5):1057-1064. doi: 10.1210/en.2018-01002.

28.

Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform.

Wu RR, Myers RA, Buchanan AH, Dimmock D, Fulda KG, Haller IV, Haga SB, Harry ML, McCarty C, Neuner J, Rakhra-Burris T, Sperber N, Voils CI, Ginsburg GS, Orlando LA.

Appl Clin Inform. 2019 Mar;10(2):180-188. doi: 10.1055/s-0039-1679926. Epub 2019 Mar 13.

29.

Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III.

Moore KE, Oberleitner LMS, Zonana HV, Buchanan AW, Pittman BP, Verplaetse TL, Angarita GA, Roberts W, McKee SA.

J Clin Psychiatry. 2019 Feb 12;80(2). pii: 18m12317. doi: 10.4088/JCP.18m12317.

PMID:
30758921
30.

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.

Davidson BA, Ehrisman J, Reed SD, Yang JC, Buchanan A, Havrilesky LJ.

Gynecol Oncol Res Pract. 2019 Jan 22;6:1. doi: 10.1186/s40661-019-0066-8. eCollection 2019.

31.

Postprocessing of all-zirconia restorations in digital dental radiographs: a quality assurance predicament.

Buchanan A, Orta A, Kalathingal S.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Apr;127(4):330-338. doi: 10.1016/j.oooo.2018.12.013. Epub 2018 Dec 31.

PMID:
30661961
32.

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.

Manickam K, Buchanan AH, Schwartz MLB, Hallquist MLG, Williams JL, Rahm AK, Rocha H, Savatt JM, Evans AE, Butry LM, Lazzeri AL, Lindbuchler DM, Flansburg CN, Leeming R, Vogel VG, Lebo MS, Mason-Suares HM, Hoskinson DC, Abul-Husn NS, Dewey FE, Overton JD, Reid JG, Baras A, Willard HF, McCormick CZ, Krishnamurthy SB, Hartzel DN, Kost KA, Lavage DR, Sturm AC, Frisbie LR, Person TN, Metpally RP, Giovanni MA, Lowry LE, Leader JB, Ritchie MD, Carey DJ, Justice AE, Kirchner HL, Faucett WA, Williams MS, Ledbetter DH, Murray MF.

JAMA Netw Open. 2018 Sep 7;1(5):e182140. doi: 10.1001/jamanetworkopen.2018.2140.

33.

Empanadas.

Buchanan AH.

Fam Med. 2019 Jan;51(1):58. doi: 10.22454/FamMed.2019.164585. No abstract available.

34.

A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder.

Donovan K, Kogut S, Buchanan A, Wen X, Crausman R.

J Opioid Manag. 2018 Nov/Dec;14(6):407-413. doi: 10.5055/jom.2018.0473.

35.

Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ.

J R Stat Soc Ser A Stat Soc. 2018 Oct;181(4):1193-1209. doi: 10.1111/rssa.12357. Epub 2018 Feb 26.

36.

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.

Chodorge M, Celeste AJ, Grimsby J, Konkar A, Davidsson P, Fairman D, Jenkinson L, Naylor J, White N, Seaman JC, Dickson K, Kemp B, Spooner J, Rossy E, Hornigold DC, Trevaskis JL, Bond NJ, London TB, Buchanan A, Vaughan T, Rondinone CM, Osbourn JK.

Sci Rep. 2018 Dec 3;8(1):17545. doi: 10.1038/s41598-018-35869-4.

37.

Computational Design of Epitope-Specific Functional Antibodies.

Nimrod G, Fischman S, Austin M, Herman A, Keyes F, Leiderman O, Hargreaves D, Strajbl M, Breed J, Klompus S, Minton K, Spooner J, Buchanan A, Vaughan TJ, Ofran Y.

Cell Rep. 2018 Nov 20;25(8):2121-2131.e5. doi: 10.1016/j.celrep.2018.10.081.

38.

Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group.

Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, Dagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF, Muessig KR, O'Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM, Weaver MA, Williams MS, Evans JP, Goddard KAB; ClinGen Resource.

Hum Mutat. 2018 Nov;39(11):1677-1685. doi: 10.1002/humu.23631.

39.

Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.

Sudfeld CR, Buchanan A, Ulenga N, Spiegelman D, Mtisi E, Hertzmark E, Muya AN, Sando D, Mungure E, Mizinduko M, Fawzi WW.

AIDS. 2019 Jan 27;33(1):93-100. doi: 10.1097/QAD.0000000000002033.

40.

Re-imagining occupational wellbeing: Development of an evidence-based framework.

Saraswati JMR, Milbourn BT, Buchanan AJ.

Aust Occup Ther J. 2019 Apr;66(2):164-173. doi: 10.1111/1440-1630.12528. Epub 2018 Oct 1.

PMID:
30276827
41.

Effects of Low- and High-Mineral Content Water on the Relative Bioavailability of a Coformulated Abacavir/Dolutegravir/Lamivudine Dispersible Tablet in Healthy Adults.

Singh RP, Shaik JSB, Skoura N, Joshi S, Shreeves T, Casillas L, Buchanan AM.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):631-638. doi: 10.1097/QAI.0000000000001859.

42.

Use of Immersive Learning and Simulation Techniques to Teach and Research Opioid Prescribing Practices.

Heirich MS, Sinjary LS, Ziadni MS, Sacks S, Buchanan AS, Mackey SC, Newmark JL.

Pain Med. 2019 Mar 1;20(3):456-463. doi: 10.1093/pm/pny171. Erratum in: Pain Med. 2019 Oct 1;20(10):2081.

43.

A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort.

Schwartz MLB, McCormick CZ, Lazzeri AL, Lindbuchler DM, Hallquist MLG, Manickam K, Buchanan AH, Rahm AK, Giovanni MA, Frisbie L, Flansburg CN, Davis FD, Sturm AC, Nicastro C, Lebo MS, Mason-Suares H, Mahanta LM, Carey DJ, Williams JL, Williams MS, Ledbetter DH, Faucett WA, Murray MF.

Am J Hum Genet. 2018 Sep 6;103(3):328-337. doi: 10.1016/j.ajhg.2018.07.009. Epub 2018 Aug 9.

44.

Rx for addiction and medication safety: An evaluation of teen education for opioid misuse prevention.

Patry E, Bratberg JP, Buchanan A, Paiva AL, Balestrieri S, Matson KL.

Res Social Adm Pharm. 2019 Aug;15(8):917-924. doi: 10.1016/j.sapharm.2018.07.006. Epub 2018 Jul 7.

PMID:
30076091
45.

Assessing Individual and Disseminated Effects in Network-Randomized Studies.

Buchanan AL, Vermund SH, Friedman SR, Spiegelman D.

Am J Epidemiol. 2018 Nov 1;187(11):2449-2459. doi: 10.1093/aje/kwy149.

46.

Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in rats.

Buss N, Lapointe JM, de Haan L, Price S, Ahnmark A, Irving L, Buchanan A, Keyes F, Davidsson P, Dixit R, Lindén D.

Toxicol Appl Pharmacol. 2018 Sep 15;355:147-155. doi: 10.1016/j.taap.2018.06.033. Epub 2018 Jul 2.

PMID:
30008375
47.

Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background.

Ormond KE, Hallquist MLG, Buchanan AH, Dondanville D, Cho MK, Smith M, Roche M, Brothers KB, Coughlin CR 2nd, Hercher L, Hudgins L, Jamal S, Levy HP, Raskin M, Stosic M, Uhlmann W, Wain KE, Currey E, Faucett WA.

Genet Med. 2019 Mar;21(3):727-735. doi: 10.1038/s41436-018-0093-6. Epub 2018 Jul 6.

48.

Functional connectivity of reflective and brooding rumination in depressed and healthy women.

Satyshur MD, Layden EA, Gowins JR, Buchanan A, Gollan JK.

Cogn Affect Behav Neurosci. 2018 Oct;18(5):884-901. doi: 10.3758/s13415-018-0611-7.

PMID:
29949111
49.

Implementation, adoption, and utility of family health history risk assessment in diverse care settings: evaluating implementation processes and impact with an implementation framework.

Wu RR, Myers RA, Sperber N, Voils CI, Neuner J, McCarty CA, Haller IV, Harry M, Fulda KG, Cross D, Dimmock D, Rakhra-Burris T, Buchanan AH, Ginsburg GS, Orlando LA.

Genet Med. 2019 Feb;21(2):331-338. doi: 10.1038/s41436-018-0049-x. Epub 2018 Jun 6.

50.

Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis.

Vermey BG, Buchanan A, Chambers GM, Kolibianakis EM, Bosdou J, Chapman MG, Venetis CA.

BJOG. 2019 Jan;126(2):209-218. doi: 10.1111/1471-0528.15227. Epub 2018 May 8.

Supplemental Content

Loading ...
Support Center